JP2020508984A5 - - Google Patents

Download PDF

Info

Publication number
JP2020508984A5
JP2020508984A5 JP2019543282A JP2019543282A JP2020508984A5 JP 2020508984 A5 JP2020508984 A5 JP 2020508984A5 JP 2019543282 A JP2019543282 A JP 2019543282A JP 2019543282 A JP2019543282 A JP 2019543282A JP 2020508984 A5 JP2020508984 A5 JP 2020508984A5
Authority
JP
Japan
Prior art keywords
collagen
seq
binding
polypeptide
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019543282A
Other languages
English (en)
Japanese (ja)
Other versions
JP7397440B2 (ja
JP2020508984A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/017665 external-priority patent/WO2018148573A1/en
Publication of JP2020508984A publication Critical patent/JP2020508984A/ja
Publication of JP2020508984A5 publication Critical patent/JP2020508984A5/ja
Priority to JP2023044982A priority Critical patent/JP7682503B2/ja
Application granted granted Critical
Publication of JP7397440B2 publication Critical patent/JP7397440B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019543282A 2017-02-10 2018-02-09 コラーゲン結合薬剤組成物およびその使用方法 Active JP7397440B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023044982A JP7682503B2 (ja) 2017-02-10 2023-03-22 コラーゲン結合薬剤組成物およびその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762457410P 2017-02-10 2017-02-10
US62/457,410 2017-02-10
PCT/US2018/017665 WO2018148573A1 (en) 2017-02-10 2018-02-09 Collagen-binding agent compositions and methods of using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023044982A Division JP7682503B2 (ja) 2017-02-10 2023-03-22 コラーゲン結合薬剤組成物およびその使用方法

Publications (3)

Publication Number Publication Date
JP2020508984A JP2020508984A (ja) 2020-03-26
JP2020508984A5 true JP2020508984A5 (enExample) 2021-03-25
JP7397440B2 JP7397440B2 (ja) 2023-12-13

Family

ID=63107889

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019543282A Active JP7397440B2 (ja) 2017-02-10 2018-02-09 コラーゲン結合薬剤組成物およびその使用方法
JP2023044982A Active JP7682503B2 (ja) 2017-02-10 2023-03-22 コラーゲン結合薬剤組成物およびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023044982A Active JP7682503B2 (ja) 2017-02-10 2023-03-22 コラーゲン結合薬剤組成物およびその使用方法

Country Status (3)

Country Link
US (1) US11624060B2 (enExample)
JP (2) JP7397440B2 (enExample)
WO (1) WO2018148573A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9579273B2 (en) * 2011-12-14 2017-02-28 The Kitasato Institute Delivery of therapeutic agents by a collagen binding protein
US11624060B2 (en) * 2017-02-10 2023-04-11 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same
US12403179B2 (en) * 2021-02-18 2025-09-02 The Board Of Trustees Of The University Of Arkansas Release of growth factors at wound healing stages

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516421D0 (en) 1985-06-28 1985-07-31 Biotechnology Interface Ltd Fibronectins
JP2950520B2 (ja) 1993-04-02 1999-09-20 アンティキャンサー インコーポレーテド 毛胞に有益な配合物を送達する方法
AU3819497A (en) 1996-07-31 1998-02-20 General Hospital Corporation, The Novel parathyroid hormone-related peptide analogs
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US6387663B1 (en) 1998-07-31 2002-05-14 University Of Southern California Targeting pharmaceutical agents to injured tissues
US7601685B2 (en) 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
CN1347456A (zh) 1999-02-19 2002-05-01 泰尔茂株式会社 胶原结合生理活性多肽
US20020102709A1 (en) 1999-02-19 2002-08-01 Tetsuya Ishikawa Collagen-binding physiologically active polypeptide
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
US7396664B2 (en) 1999-06-08 2008-07-08 Regeneron Pharmaceuticals, Inc. VEGF-binding fusion proteins and nucleic acids encoding the same
US20050124537A1 (en) 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
EP1314780A4 (en) 2000-08-15 2004-07-28 Terumo Corp Collagen-binding hybrid polypeptides
JP2002058485A (ja) 2000-08-16 2002-02-26 Terumo Corp コラーゲン結合性を有する骨形成促進融合蛋白質
CA2470419A1 (en) 2001-12-18 2003-06-26 Eidgenossisch Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
JP2003284553A (ja) * 2002-03-28 2003-10-07 Seikagaku Kogyo Co Ltd 生理活性タンパク質
CA2492295C (en) 2002-07-25 2014-01-28 The General Hospital Corporation Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
CA2516113A1 (en) 2003-02-13 2004-08-26 Synthes (U.S.A.) Injectable bone-replacement mixture
US20040220094A1 (en) 2003-05-01 2004-11-04 Skinner Keith K. Inverse agonist and agonist peptides that stimulate/inhibit hair growth
WO2005046798A1 (en) 2003-11-12 2005-05-26 Nps Allelix Corp. Treatment of bone loss utilizing full length parathyroid hormone
EP1557176A1 (en) 2004-01-26 2005-07-27 Ferring B.V. Treatment of bone metastases by means of PTH receptor agonists
US8030448B2 (en) 2004-02-16 2011-10-04 Techno Network Shikoku Co., Ltd. Polypeptide having collagen-like structure
PL1759001T3 (pl) 2004-04-21 2011-09-30 Alexion Pharma Inc Koniugaty dostarczane do kości i sposób ich zastosowania do nakierowywania białek do kości
WO2006073711A2 (en) 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
ATE514712T1 (de) 2005-12-26 2011-07-15 Yantai Zhenghai Bio Technology Co Ltd Aktivierte collagen-gerüstmaterialien und ihre speziellen kondensierten aktiven restorationsfaktoren
JP5645408B2 (ja) 2006-11-16 2014-12-24 カイ ファーマシューティカルズ インコーポレーティッド 副甲状腺機能亢進症および高カルシウム血症性障害の治療のためのポリカチオン性カルシウムモジュレーターペプチド
WO2008101406A1 (en) 2007-02-14 2008-08-28 Yolare Dermaceuticals, Llc Modified mutant collagenase and it's use in fat melting and in scar reduction
ES2583002T3 (es) 2007-04-09 2016-09-16 The Board Of Trustees Of The University Of Arkansas Proteínas de fusión de un dominio de enlazamiento a colágeno y hormona paratiroidea
US8486422B2 (en) 2007-07-26 2013-07-16 Allergan, Inc. Methods of activating clostridial toxins
US20100159564A1 (en) 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
JP2010172247A (ja) 2009-01-29 2010-08-12 Kitasato Institute 積層型高密度培養人工組織の製造方法及び積層型高密度培養人工組織
WO2011060431A2 (en) 2009-11-16 2011-05-19 University Of Maryland Baltimore Multivalent live vector vaccine against clostridium difficile-associated disease
WO2011142425A1 (ja) 2010-05-12 2011-11-17 国立大学法人香川大学 上皮層含有組織の再生材および再生評価方法
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
ES2726530T3 (es) 2011-03-16 2019-10-07 Univ Tohoku Sonda para analizar tejido biológico y método para utilizar la misma
WO2012157339A1 (ja) 2011-05-13 2012-11-22 学校法人北里研究所 成長因子アンカーリング型骨移植材料、成長因子アンカーリング型骨移植材料の製造方法、成長因子アンカーリング型骨移植材料製造用キット、および骨形成方法
US9579273B2 (en) 2011-12-14 2017-02-28 The Kitasato Institute Delivery of therapeutic agents by a collagen binding protein
WO2013120060A1 (en) 2012-02-09 2013-08-15 The Board Of Trustees Of The University Of Arkansas Delivery of therapeutic agents by a collagen binding protein
EP4772625A2 (en) 2012-01-12 2026-07-08 Endo Biologics Limited Clostridium histolyticum enzyme
WO2013120030A1 (en) 2012-02-08 2013-08-15 Shining Golden Yida Welding & Cutting Machinery Manufacture Ltd. Rotary vane air motor with improved vanes and other improvements
JP6403062B2 (ja) 2012-12-21 2018-10-10 国立大学法人徳島大学 組織修復活性組成物及びその利用
SG11201602012RA (en) 2013-09-25 2016-04-28 Pronutria Inc Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
US9539363B2 (en) 2014-04-24 2017-01-10 Warsaw Orthopedic, Inc. Collagen matrix
US20180140742A1 (en) 2014-10-16 2018-05-24 School Juridical Person Kitasato Institute Graft material for nerve regeneration, method for producing graft material for nerve regeneration, and kit for producing graft material for nerve regeneration
EP3112474A1 (en) 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis
HUE063235T2 (hu) 2016-09-29 2024-01-28 Ascendis Pharma Bone Diseases As Adagolási rendszer szabályozott leadású PTH vegyülethez
US11624060B2 (en) 2017-02-10 2023-04-11 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same
WO2019113123A1 (en) 2017-12-04 2019-06-13 Precithera, Inc. TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING
WO2019147735A1 (en) 2018-01-23 2019-08-01 New York University Antibodies specific to delta 1 chain of t cell receptor
JP2021516966A (ja) 2018-03-09 2021-07-15 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 組織への生物学的薬物の送達

Similar Documents

Publication Publication Date Title
Rothe et al. Growth factors: their biology and promise in dermatologic diseases and tissue repair
RU2468080C2 (ru) Новый класс терапевтических белковых молекул
Thomas et al. Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity
CN102718858B (zh) 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用
JP4319227B2 (ja) マクロファージ炎症蛋白変種をコードするポリヌクレオチド
US20170335311A1 (en) Chimeric protein
JP2018104461A5 (enExample)
JPH0699322B2 (ja) 傷の治癒
JP2015513312A5 (enExample)
CA2223701A1 (en) Fgf9 as a specific ligand for fgfr3
MXPA01007956A (es) Polipeptido antimicrobiano/neutralizador de endotoxina.
US20070021342A1 (en) Wound Healing
JPH03500782A (ja) 創傷の治癒
JP2000506894A (ja) 中枢神経系の虚血または外傷の機能的回復を増大させる方法
JP2009515529A5 (enExample)
RU99107759A (ru) Применение антагонистов лептина для лечения резистентности к инсулину при диабете ii типа
JP2005506275A5 (enExample)
CN1643140A (zh) 生长因子和蛋白酶的组合
US20150313967A1 (en) Methods and Agents for Wound Healing
JPH0768139B2 (ja) 創傷の治癒
WO2021087561A1 (en) Cytokine or growth factor fusion proteins
JP2023088982A (ja) コラーゲン結合薬剤組成物およびその使用方法
JP2025060836A5 (enExample)
KR19990022716A (ko) 골 자극 인자
KR20060106606A (ko) 조직재생 기능을 가지는 비활성 폴리펩티드 및 그 제조방법